Evidence map›Paper›PMID 26472317›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2015

The impact of radiotherapy costs on clinical outcomes in breast cancer.

Isabel J Boero, Anthony J Paravati, Daniel P Triplett, Lindsay Hwang, Rayna K Matsuno, Loren K Mell, James D Murphy

Open access · greenAbstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Economic burden of breast cancer: a case of Southern Iran.Cost effectiveness and resource allocation : C/E · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Isabel J BoeroDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, United States.
Anthony J ParavatiDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, United States.
Daniel P TriplettDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, United States.
Lindsay HwangDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, United States.
Rayna K MatsunoDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, United States.
Loren K MellDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, United States.
James D MurphyDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, United States. Electronic address: j2murphy@ucsd.edu.
University of California, San Diego · US

Funding

UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
San Diego Clinical and Translational Research InstituteTL1TR000098 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S · 2012 to 2014
$860k
San Diego Clinical and Translational Research InstituteKL2RR031978 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S · 2010 to 2011
$615k
NCATS NIH HHS KL2 TR001444NCATS NIH HHS TL1 TR000098NCATS NIH HHS TL1 TR00098NCRR NIH HHS KL2 RR031978
6 · The paper itself

Abstract

background and purposeIn cost-effective healthcare systems, the cost of services should parallel patient complexity or quality of care. The purpose of this study was to determine whether the cost of radiotherapy correlates with patient-related outcomes among a large cohort of breast cancer patients treated with adjuvant breast radiation. MATERIALS AND

methods23,127 women with non-metastatic breast cancer undergoing radiotherapy after breast conservation surgery were identified from the Surveillance, Epidemiology, and End Results database from 2000 to 2009. Medicare reimbursements were used as a proxy for cost of radiotherapy, and Medicare claims were examined to identify local toxicities, and breast cancer-related endpoints. The impact of cost on these outcomes was studied with multivariable Fine-Gray models to account for competing risks.

resultsThe median cost (and interquartile range) of a course of breast radiation was $8100 ($6700-9700). Increased radiation costs were not associated with the occurrence of treatment-related toxicities (all p-values>0.05), ipsilateral breast recurrence (p=0.55), or breast cancer-related mortality (p=0.55).

conclusionHigher costs for adjuvant radiation in breast cancer were not associated with a decreased risk of patient-related outcomes suggesting inefficiency in Medicare reimbursements. Future efforts should focus on prospective evaluation of alternative payment models for radiotherapy.

Indexed as

AgedAged, 80 and overBreast NeoplasmsFemaleHumansTreatment OutcomeBreast cancerCostsOutcomesRadiation therapy

Identifiers

PMID26472317
PMCPMC4758206
OpenAlexW2108174404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.